Business model and Advantages

One of the characteristics that sets us apart from other companies in China is our enthusiasm for undertaking the most challenging projects and our willingness to co-invest with clients. We possess an extremely profound understanding of and the corresponding resource organization capabilities across the following dimensions:

sourcing of low-cost but regulatory-compliant active pharmaceutical ingredients (APIs), which can be customized and developed for clients based on project requirements;

avoid the source of patented crystalline active pharmaceutical ingredients;

development of 505B2 category products;

global patent portfolio;

development, production, and technology transfer of complex formulations such as liposomes, microspheres, and suspension injections;

co-investing with clients in product development, selecting suitable CDMO facilities in China, India, and Europe for production.